Kenneth John Shelly is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of medical technology, particularly in the area of boron neutron capture therapy. With a total of 4 patents, his work focuses on innovative methods for delivering boron to mammalian tissues to enhance cancer treatment.

Latest Patents

Shelly's latest patents include groundbreaking methods for boron delivery to mammalian tissue. His research emphasizes the use of boron neutron capture therapy to destroy tumors effectively. This treatment modality is enhanced by delivering compounds to the tumor site, where they achieve high concentrations of boron. The boron compounds are encapsulated in the bilayer of liposomes, which may also contain carborane units with multiple boron atoms within their structure. Additionally, he has developed compositions for boron delivery that utilize various borane salts, which can be used free or encapsulated in liposomes to improve tumor specificity.

Career Highlights

Kenneth John Shelly is affiliated with the University of California, where he continues to advance his research in medical technology. His innovative approaches have the potential to significantly impact cancer treatment methodologies.

Collaborations

Some of his notable coworkers include Marion Frederick Hawthorne and Debra Arlene Feaks, who have collaborated with him on various projects related to his patents.

Conclusion

Kenneth John Shelly's contributions to boron neutron capture therapy represent a significant advancement in cancer treatment. His innovative methods and collaborations continue to pave the way for future research and development in this critical field.